This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Berman RM, Cappiello A, Anand A, Oren DA, Heninger GR, Charney DS et al. Biol Psychiatry 2000; 47: 351–354.
Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al. Arch Gen Psychiatry 2006; 63: 856–864.
Li N, Lee B, Liu RJ, Banasr M, Dwyer JM, Iwata M et al. Science 2010; 329: 959–964.
Maeng S, Zarate Jr CA, Du J, Schloesser RJ, McCammon J, Chen G et al. Biol Psychiatry 2008; 63: 349–352.
Machado-Vieira R, Salvadore G, Diazgranados N, Zarate Jr CA . Pharmacol Ther 2009; 123: 143–150.
De Sarno P, Bijur GN, Zmijewska AA, Li X, Jope RS . Neurobiol Aging 2006; 27: 413–422.
Li X, Jope RS . Neuropsychopharmacol 2010; 35: 2143–2154.
Jope RS, Johnson GV . Trends Biochem Sci 2004; 29: 95–102.
McManus EJ, Sakamoto K, Armit LJ, Ronaldson L, Shpiro N, Marquez R et al. EMBO J 2005; 24: 1571–1583.
Klein PS, Melton DA . Proc Natl Acad Sci USA 1996; 93: 8455–8459.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
PowerPoint slides
Rights and permissions
About this article
Cite this article
Beurel, E., Song, L. & Jope, R. Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice. Mol Psychiatry 16, 1068–1070 (2011). https://doi.org/10.1038/mp.2011.47
Published:
Issue date:
DOI: https://doi.org/10.1038/mp.2011.47